A high ALDH1 expression level has been used as a biomarker predicting a poor prognosis in breast cancer, serous ovarian cancer, colorectal cancer, and several other tumors [21]–[23]. The gene discussed is ALDH1A1; the disease is ovarian serous adenocarcinoma.